Webinars

Hear industry perspectives from expert panelists in our on-demand webinar presentations about optimizing the measurement of cognition.

Measuring Cognitive Effects of Pediatric Oncology Treatments Using Computerized Assessments

May 15, 2019

In recent years the neurocognitive effects of treatments for pediatric cancers have been acknowledged in the scientific literature. However, in many cases the magnitude of these deficits and the long-term impact on cognitive maturation remain unclear. Children and adolescents present a particularly challenging population, given neurocognitive effects may impact developmental trajectories, and patients are often so unwell at the time of testing that brevity, flexibility and adaptability of the neuropsychological testing need to be considered. With the availability of computerized cognitive assessments, recent studies have more readily included longitudinal assessments of neurocognitive function.

Access Recording

Evaluating Cognition in Parkinson’s Disease Clinical Trials

March 20, 2019

The past two decades have seen multiple industry trials explore the impact of drug treatments (primarily dopaminergic therapies and cholinesterase inhibitors) on cognition in Parkinson’s disease (PD) and PD dementia (PDD).

Access Recording

How to Leverage eCOA for Improved Signal Detection in Pediatric & Rare Disorder Trials

March 4, 2019

Combining eSource Technology with Expert Clinical Science to Reduce Rater Errors on Cognitive, Behavioral and Developmental Assessments for Infants to Young Adults.

Access Recording

Cogstate Solutions for Clinical Practice

June 18, 2018

How will healthcare providers manage increasing resource demands needed to care for patients with cognitive impairment? Rapid and reliable cognitive assessment can play a pivotal role in the growing brain health epidemic.

Access Recording

Delirium and POCD – What’s the prevalence? How are they defined? How can they be measured?

June 18, 2018

Brain Health Complications, such as POCD and Delirium, are an enormous burden on Healthcare providers around the world, and measurement and monitoring are critical for effective management of these conditions.

Access Recording

Selecting CNS Endpoint Measures in Pediatric and Rare Disease Clinical Trials: Key Considerations for Cognitive and Behavioral Assessments

May 21, 2018

Featured Speaker

  • Pamela Ventola – Senior Science Director, Pediatrics and Rare Disease

Access Recording

The ABCs of Assessing Cognition in Oncology Clinical Trials: Applications, Benefits, and Considerations

May 17, 2017

Featured Speaker

  • Jeffrey S. Wefel, PhD, ABPP, Section Chief and Associate Professor, Section of Neuropsychology, Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center

Access Recording

Increasing the Precision of Cognitive Endpoints in Schizophrenia Clinical Trials

February 13, 2017

Featured Speaker:

  • Paul Maruff – Chief Science Officer, Cogstate

Access Recording

Optimizing CNS Endpoints Using Technology-enabled Workflows

November 16, 2016

Featured Speakers:

  • Pamela Bynum – Learning & Operational Excellence Director, Cogstate
  • Daniella Mulder – Senior Director of Project Management, Clinical Ink
  • Lisle Kingery, PhD – Clinical Science Director, Cogstate

Access Recording

The Preclinical Alzheimer Cognitive Composite: From Theory to Practical Application in Global Clinical Trials

September 6, 2016

Featured Speakers:

  • Paul Maruff – Chief Science Officer
  • Edward Bartolic – Senior Science Director

Access Recording